NCT 00694707.
Methods | Allocation: randomised.
Blindness: double. Duration: 6 weeks. Design: parallel. |
Participants | Diagnosis: people with schizophrenia. |
Interventions | 1. Risperidone: dose 4 mg/day.
2. Placebo. 3. Cariprazine 1.5 mg/d. 4. Cariprazine 3 mg/d. 5. Cariprazine 4.5 mg/d. |
Outcomes | Not reported. |
Notes | Awaiting for full text. |